Skip to content

Wide Area Circular Ablation Versus Extra-wide Area Circular Ablation in Persistent Atrial Fibrillation

Comparison of Wide Area Circular Ablation With Extra-wide Area Circular Ablation in Subjects With Persistent Atrial Fibrillation, a Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02814136
Acronym
WACAvsEWACA
Enrollment
146
Registered
2016-06-27
Start date
2016-07-31
Completion date
2021-07-31
Last updated
2019-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Ablation of atrial fibrillation is an established method for treatment of subjects with atrial fibrillation with goal of restoration of sinus rhythm. Among different methods, wide area circular ablation (WACA) is shown to provide the same results with fewer complications. This project will compare WACA with extra-wide area circular ablation (E-WACA) in subjects who are considered for ablation of atrial fibrillation.

Interventions

PROCEDUREAblation

Sponsors

Mosaic Life Care
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All subjects with symptomatic persistent atrial fibrillation who are scheduled for clinically indicated ablation of AF.

Exclusion criteria

* Subjects younger than 18 year of age. * Subjects who are pregnant. * Subjects who are unable to provide consent.

Design outcomes

Primary

MeasureTime frame
To evaluate the achievement of sinus rhythm in subjects undergoing ablation of atrial fibrillation using WACA compared to E-WACA.1 year

Secondary

MeasureTime frame
ii. To compare the time to reoccurrence of atrial fibrillation, atrial flutter and/or atrial tachycardia in subjects undergoing ablation of atrial fibrillation using WACA compared to E-WACA.1 year

Other

MeasureTime frame
iii. To assess the frequency of complications in subjects undergoing ablation of atrial fibrillation using WACA compare to E-WACA.1 year

Countries

United States

Contacts

Primary ContactTrisha D England, MSN
trisha.england2@mymlc.com816-271-7937
Backup ContactPaula S Wilson, MSN
paula.wilson@mymlc.com816-271-6718

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026